Table 2.
Clinical Presentation of Restenosis and Stenosis Patients of the Study Population Stratified by Gender
| Men | Women | ||||||
|---|---|---|---|---|---|---|---|
| Restenosis (1296) | Stenosis (2559) | p.value | Restenosis (376) | Stenosis (1010) | p.value | ||
| T2D | No | 830 (64.1%) | 1721 (67.3%) | 0.048 | 201 (53.5%) | 611 (60.6%) | 0.017 |
| Yes | 464 (35.9%) | 835 (32.7%) | 175 (46.5%) | 398 (39.4%) | |||
| Hypertension | No | 444 (34.3%) | 1121 (43.9%) | < 0.001 | 62 (16.5%) | 238 (23.6%) | 0.004 |
| Yes | 850 (65.7%) | 1435 (56.1%) | 314 (83.5%) | 771 (76.4%) | |||
| Dyslipidemia | No | 471 (36.3%) | 1430 (55.9%) | < 0.001 | 116 (30.9%) | 465 (46.0%) | < 0.001 |
| Yes | 825 (63.7%) | 1129 (44.1%) | 260 (69.1%) | 545 (54.0%) | |||
| Age | 63.016 (10.319) | 61.219 (11.180) | < 0.001 | 66.784 (9.819) | 65.579 (10.461) | 0.053 | |
| Weight | 81.847 (13.375) | 81.734 (14.962) | 0.821 | 72.087 (12.655) | 72.470 (14.554) | 0.658 | |
| BMI | 28.695 (4.189) | 28.479 (4.923) | 0.185 | 30.048 (4.982) | 30.335 (6.047) | 0.426 | |
| FBS | 126.785 (53.685) | 126.504 (57.251) | 0.916 | 141.115 (61.763) | 132.429 (62.841) | 0.138 | |
| HDL | 36.758 (9.978) | 37.268 (10.698) | 0.193 | 43.486 (13.399) | 43.853 (13.144) | 0.684 | |
| LDL | 103.411 (45.995) | 113.419 (42.355) | < 0.001 | 101.985 (52.971) | 113.619 (42.173) | < 0.001 | |
| Total Cholesterol | 172.431 (48.315) | 184.360 (46.688) | < 0.001 | 178.280 (57.641) | 190.827 (48.663) | < 0.001 | |
| Triglyceride | 149.999 (117.811) | 157.955 (128.412) | 0.063 | 142.868 (134.575) | 145.317 (114.541) | 0.737 | |
Notes: Values are presented as n (%) or mean (SD). P.value is generated with χ2 test (categorical variables) and ANOVA (continuous variables). Restenosis: Patients with coronary artery disease (CAD) >50% and stent deployment or coronary artery bypass graft (CABG) surgery. Stenosis: patients with CAD >50% and no stent deployment or CABG. T2D, type 2 diabetes. FBS, fasting Blood sugar. Statistically significant values (p.value <0.05) are emphasized in bold.